Study of blood/tissue targets in suspected childhood brain tumors
Part of Cancer clinical trials.
This study looks at biological “targets” (things in the body) to help guide future medical treatments for children and teens with suspected craniopharyngioma. It will collect and analyze tissue samples from planned care to understand what therapies might work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 0 to 21 years.
- You have a diagnosis or strong suspicion of craniopharyngioma (a childhood brain tumor near the pituitary).
- Your planned care includes getting a tissue sample (biopsy or surgery tissue).
- The tissue test (final pathology) must confirm adamantinomatous craniopharyngioma.
- A tissue specimen must be available for the study to use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a targeted medicine approach for high-grade glioma (a fast-growing brain tumor) and some diffuse midline tumors, including DIPG. It may help by matching treatment to tumor biology using tumor testing done before or around starting standard therapy.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study collects biological samples from adults with a confirmed brain tumor. Samples may help researchers better understand brain tumors and improve future treatments.
This trial studies how brain tumors (like high-risk gliomas, medulloblastoma, and ependymoma) respond to treatment and why they sometimes become resistant. It is for young people aged 15 to 39 and aims to use tumor tissue samples to understand the tumor better and guide future therapies.
This trial studies newly diagnosed or progressing brain tumors (grade 2–4 gliomas) to better understand the disease using tumor tissue and blood samples. It may help doctors learn which treatments could work best for different tumor types by matching tumor material to blood results.
This trial looks at how craniopharyngioma, a rare brain tumor, affects pregnancy. Researchers want to learn more about health outcomes for women who have or had this tumor.
Hear when a new Craniopharyngioma, Child trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.